McKesson Acquiring US Oncology

McKesson Grabs USO in $2 Billion Deal

McKesson is acquiring US Oncology in a deal valued at $2.16 billion. The combined organization will focus on providing a comprehensive offering of solutions for the oncology industry, they stated. “The unified organization will bring together the collective capabilities of McKesson and US Oncology to provide oncology customers access to:

• Leading evidence-based medicine offerings that drive continued improvements in clinical outcomes and enable value-based reimbursement;
• Expanded clinical expertise, clinical research and personalized medicine offerings;
• Integrated, efficiency-enabling healthcare information technology, including the iKnowMed and Lynx technology platforms, facilitating outcomes measurement, reporting, and advanced product and inventory management;
• Innovative practice-management solutions and consultative capabilities that allow independent community specialists to thrive in a changing healthcare environment; and
• Superior distribution capabilities and supply-chain expertise.”